FountainRx Specialty Pharmacy
Derek Hicks is an experienced healthcare professional with extensive expertise in clinical pharmacy. Currently serving as Chief Clinical Officer at BrookWell Infusion since April 2020, Derek oversees clinical services and collaborates with the management team. Concurrently, Derek holds the role of Chief Clinical Officer at FountainRx since January 2016, managing operations related to specialty compounding and providing training in specialty pharmaceuticals. Prior experience includes serving as Pharmacist-in-Charge at Medical Center Pharmacy from 1996 to 2015, where oversight included both compounding and traditional pharmacy services, and as Clinical Pharmacy Specialist at Blount Memorial Hospital from 1992 to 1996, focusing on developing clinical pharmacy services. Educational credentials include a Doctor of Pharmacy (Pharm.D.) from Mercer University and a General Clinical Pharmacy Residency with an emphasis on infectious disease and pharmacokinetics.
This person is not in any teams
FountainRx Specialty Pharmacy
FountainRx is a national independently-owned specialty pharmacy serving people across the U.S. living with complex and persistent health conditions. We carefully fulfill prescription specialty medications, provide specialty and infusion treatment services, and are committed to comprehensive support to ensure patients’ understanding and success with their treatments and therapies. In going the extra mile, our experts in care are unwaveringly committed to better treatment outcomes for the people we serve every day. At FountainRx, we are committed to playing a key role in the health and healing of our patients. We lead with compassion, fervently serving our patients, providers and payers with integrity, excellence and stellar service. Our state-of-the-art pharmacy and extensive network have enabled us to become highly effective and patient-centric. We integrate knowledge and expertise to formulate creative and customized medication solutions, maximizing the potential for positive therapeutic outcomes while helping to reduce the overall cost of care to the healthcare system.